Senate Bill, 88th Legislature, Regular Session (2023)
SB 241
Relating to written notification provided by drug manufacturers regarding the cause of generic or biosimilar insulin prescription drug unavailability.
Filed by Sen. Perry (R).
How far it got in 2023
Became law
Last official action May 27, 2023.
We keep a summary of each 2023 bill. Its full history, text, amendments, and votes are on Texas Legislature Online.